Human Stem Cell-Based Retina on Chip as New Translational Model for Validation of AAV Retinal Gene Therapy Vectors

By employing their recently developed retina on chip that merged organoid and organ-on-chip technology, scientists analyzed the efficacy, kinetics, and cell tropism of seven first- and second-generation adeno-associated virus (AAV) vectors.